| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,170 |
30,465 |
$2.42M |
| 99199 |
Unlisted special service, procedure or report |
258,610 |
135,128 |
$1.34M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,987 |
11,555 |
$1.27M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,683 |
6,529 |
$631K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,344 |
5,165 |
$551K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,896 |
5,737 |
$539K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,745 |
3,576 |
$326K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,086 |
14,629 |
$285K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,556 |
6,395 |
$166K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,974 |
2,777 |
$145K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,871 |
4,954 |
$142K |
| D0145 |
Oral evaluation for a patient under three years of age |
4,131 |
4,016 |
$139K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,570 |
6,232 |
$90K |
| D1206 |
Topical application of fluoride varnish |
4,130 |
4,015 |
$61K |
| 92567 |
|
3,451 |
3,206 |
$47K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,524 |
1,488 |
$44K |
| 90651 |
|
1,913 |
1,840 |
$43K |
| 99058 |
|
1,879 |
1,776 |
$29K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
258 |
250 |
$27K |
| 90474 |
|
1,356 |
1,337 |
$26K |
| 99381 |
|
281 |
267 |
$26K |
| 90734 |
|
1,386 |
1,335 |
$23K |
| 94664 |
|
1,939 |
1,649 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,133 |
3,058 |
$16K |
| 92551 |
|
14,407 |
13,894 |
$16K |
| 87807 |
|
1,161 |
1,047 |
$15K |
| 99050 |
|
565 |
536 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,059 |
968 |
$11K |
| 99173 |
|
14,480 |
13,977 |
$10K |
| 83655 |
|
543 |
531 |
$7K |
| 90480 |
|
120 |
109 |
$5K |
| 90473 |
|
286 |
252 |
$5K |
| 90686 |
|
6,554 |
6,456 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
25 |
$4K |
| 90715 |
|
804 |
794 |
$4K |
| 0071A |
|
37 |
37 |
$2K |
| 96127 |
|
477 |
472 |
$2K |
| 0072A |
|
27 |
27 |
$2K |
| 81002 |
|
433 |
387 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
55 |
51 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
16 |
$571.95 |
| 90672 |
|
747 |
693 |
$466.86 |
| 90619 |
|
504 |
488 |
$304.83 |
| 90633 |
|
1,803 |
1,765 |
$297.88 |
| 99051 |
|
19 |
19 |
$264.80 |
| 90688 |
|
72 |
72 |
$232.05 |
| 85018 |
|
85 |
81 |
$219.83 |
| 90697 |
|
469 |
450 |
$150.74 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
13 |
12 |
$26.00 |
| 90707 |
|
478 |
462 |
$0.00 |
| 90681 |
|
1,237 |
1,225 |
$0.00 |
| G9920 |
Screening performed and negative |
119 |
105 |
$0.00 |
| 90710 |
|
443 |
442 |
$0.00 |
| 1160F |
|
2,103 |
2,027 |
$0.00 |
| 90700 |
|
430 |
427 |
$0.00 |
| 91322 |
|
30 |
30 |
$0.00 |
| 90670 |
|
2,399 |
2,352 |
$0.00 |
| 90671 |
|
502 |
478 |
$0.00 |
| 3078F |
|
1,455 |
1,420 |
$0.00 |
| 91320 |
|
18 |
17 |
$0.00 |
| 91321 |
|
17 |
15 |
$0.00 |
| 90687 |
|
58 |
58 |
$0.00 |
| 90685 |
|
52 |
52 |
$0.00 |
| 90716 |
|
520 |
501 |
$0.00 |
| 3074F |
|
1,508 |
1,473 |
$0.00 |
| 90723 |
|
1,743 |
1,708 |
$0.00 |
| 90677 |
|
128 |
127 |
$0.00 |
| 90696 |
|
429 |
428 |
$0.00 |
| 3008F |
|
1,682 |
1,640 |
$0.00 |
| 90647 |
|
1,810 |
1,788 |
$0.00 |
| 3079F |
|
41 |
41 |
$0.00 |
| 2001F |
|
2,440 |
2,356 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
13 |
12 |
$0.00 |
| 90656 |
|
603 |
600 |
$0.00 |
| 91319 |
|
16 |
16 |
$0.00 |
| 91307 |
|
69 |
63 |
$0.00 |
| 91318 |
|
18 |
12 |
$0.00 |